UNM · Unum Group
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Strong BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| achievement of our current premium rate approval program | 15% | the second quarter | — |
| Adjusted Operating Return on Equity non-GAAP | 21.6% | Six Months Ended June 30, 2026 | — |
|
|
|||
| after-tax adjusted operating income non-GAAP | $346M | the second quarter | — |
| After-Tax Adjusted Operating Income per share non-GAAP | $2.16 | Three Months Ended June 30, 2026 | — |
| Available holding company liquidity | $1.54B | At June 30, 2026 | — |
| Average Duration (in years) non-GAAP | 8.3 | 6/30/2026 | — |
| Book value per common share | $68.28 | as of June 30, 2026 | — |
| Book value per common share excluding AOCI non-GAAP | $80.1 | as of June 30, 2026 | — |
|
|
|||
| Closed Block segment adjusted operating loss non-GAAP | $75.4M | the second quarter | — |
| Colonial Life Persistency | 78.2% | the first half | — |
| Colonial Life segment adjusted operating income non-GAAP | $131.4M | the second quarter | — |
| common stock dividends | $73.5M | the second quarter | — |
|
|
|||
| Common Stock Dividends Paid Per Share | $0.92 | Three Months Ended 6/30/2026 | — |
| Corporate segment adjusted operating loss non-GAAP | $44.5M | the second quarter | — |
| Cost of Shares Repurchased | $202.1M | Three Months Ended 6/30/2026 | — |
| dividends | $150M | year-to-date | — |
| Earned Book Yield non-GAAP | 4.23% | 6/30/2026 | — |
| Effective income tax rate non-GAAP | 21.5% | the second quarter of 2026 | — |
| Fairwind statutory reserves and excess capital above our best estimate reserves | $2.2B | the second quarter | — |
| Group short-term disability persistency | 91.1% | the first half | — |
| holding company liquidity | $1.5B | the second quarter | — |
|
|
|||
| Leverage Ratio non-GAAP | 23.9% | June 30, 2026 | — |
| Net premium ratio | 97.8% | as of March 31, 2026 | — |
| Persistency - Cancer and Critical Illness non-GAAP | 81.2% | Six Months Ended 6/30/2026 | — |
| Persistency in the accidental death and dismemberment product line | 92% | the first half | — |
| Persistency in the dental and vision product line | 78.9% | the first half | — |
| Persistency in the group long-term disability product line | 90.4% | the first half of 2026 | — |
| Persistency in the individual disability product line | 87.8% | the first half | — |
| Persistency in the supplemental product line | 92.8% | the first half of 2026 | — |
| Persistency in the voluntary benefits product line | 76% | the first half | — |
| premium growth on a constant currency basis | 3.6% | the second quarter | — |
|
|
|||
| Premium Income in Constant Currency non-GAAP | $538.5M | Six Months Ended June 30, 2026 | — |
| Shares outstanding | 158.3M | June 30, 2026 | — |
| traditional U.S. life insurance company statutory operating earnings | $330.9M | the second quarter | — |
| Unum International segment adjusted operating income non-GAAP | $24.3M | the second quarter | — |
| Unum US benefit ratio | 65.8% | the second quarter | — |
|
|
|||
| Unum US Sales | $281.8M | the second quarter | — |
|
|
|||
| Unum US segment adjusted operating income non-GAAP | $329.6M | the second quarter | — |
|
|
|||
| Weighted average number of shares outstanding, assuming dilution | 160M | the second quarter of 2026 | — |
| weighted average risk-based capital ratio | 480% | the second quarter | — |
|
|
|||
| year-to-date capital return | $750M | year-to-date | — |
| year-to-date share repurchases | $600M | year-to-date | — |
| Group long-term disability persistency | 92.2% | first three months of 2026 | — |
| Sales growth on a constant currency basis | 14.4% | first quarter of 2026 | — |
| Shares repurchased | $400M | first quarter of 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Insurance - Life — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
UNM
this stock
Unum Group
|
$14.21B | +15.8% | +1.5% | 20.8 | 1.9% |
|
CILJF
China Life Insurance Co Ltd
|
$97.80B | +0.6% | — | — | 0.0% |
|
MFC
Manulife Financial Corp
|
$73.51B | +21.4% | — | — | 0.8% |
|
MET
Metlife Inc
|
$61.44B | +22.5% | +8.6% | 18.5 | 1.8% |
|
AFL
Aflac Inc
|
$61.03B | +5.7% | -9.3% | 13.1 | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| UNM | -0.1% | +1.6% | +23.9% | +4.3% | +15.8% |
| SPY | -0.4% | +2.6% | +10.7% | +2.7% | +12.5% |
| vs SPY | +0.3% | -1.0% | +13.1% | +1.5% | +3.3% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.